Clinical trials
Phase 2 Burkitt Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Novartis Pharmaceuticals | 3 |
| Children's Oncology Group | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Incyte Corporation | 1 |
| Ottawa Regional Cancer Centre | 1 |
| Theradex | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 14 |
| Lymphoma | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Dendritic Cell Sarcoma, Interdigitating | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Leukemia | 3 |
| Lymphoma, Large-Cell, Immunoblastic | 3 |
| Astrocytoma | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.